Invention Grant
US07973029B2 Inhaled aztreonam lysine for the treatment of deficits in health-related quality-of-life in lung diseases
失效
吸入氨曲南赖氨酸用于治疗肺部疾病与健康相关的生活质量缺陷
- Patent Title: Inhaled aztreonam lysine for the treatment of deficits in health-related quality-of-life in lung diseases
- Patent Title (中): 吸入氨曲南赖氨酸用于治疗肺部疾病与健康相关的生活质量缺陷
-
Application No.: US12210965Application Date: 2008-09-15
-
Publication No.: US07973029B2Publication Date: 2011-07-05
- Inventor: Alan B. Montgomery , Melissa A. Yeager
- Applicant: Alan B. Montgomery , Melissa A. Yeager
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Agent Lorie Ann Morgan
- Main IPC: A61K31/397
- IPC: A61K31/397
Abstract:
Provided is a method of treating the health-related quality-of-life (HRQOL) symptoms of a lung disease, comprising the administration of an inhalable aerosol of aztreonam lysine. The method is suitable for the short term and sustainable long term treatment of HRQOL symptoms.
Public/Granted literature
Information query
